查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301116

被忽視的熱帶疾病診斷市場規模、份額和趨勢分析報告：按疾病、診斷方法、服務類型、最終用途、細分市場趨勢：2023-2030

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End Use, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10個工作天內

價格

被忽視的熱帶病診斷市場增長和趨勢

根據 GrandView Research, Inc. 的最新報告，到 2030 年，全球被忽視的熱帶病診斷市場將達到 89.7 億美元，預測期內復合年增長率為 4.5%。預計將擴大。

疾病負擔的增加、疾病早期檢測需求的增加以及技術的互補進步預計將推動需求增長。

人們對被忽視的熱帶病及其對經濟和人口影響的興趣日益濃厚，推動了對早期疾病檢測方法開發的需求。 這種日益增長的關注反映在一系列旨在對抗被忽視熱帶病的計劃的啟動上。 例如，被忽視的熱帶病全球網絡致力於提高人們的認識並提供資金，這對於消除最常見的被忽視的熱帶疾病至關重要。 此外，多家公司正在努力開發更複雜、更便宜的熱帶病診斷方法。 2021年1月，諾華公司與世界衛生組織簽署了全球控制麻風病的協議。 預計這將在預測期內支持該市場的增長。

根據世界衛生組織的數據，截至 2022 年 1 月，全球有超過 15 億人患有土源性蠕蟲感染。 Kato-Katz 方法是 WHO 的黃金標準，廣泛用於診斷 STH 的嚴重程度。 這些傳染病廣泛分佈於熱帶和亞熱帶地區，在美國、撒哈拉以南非洲、東亞和中國頻繁發生。 此外，主要參與者的存在預計將推動整個市場的增長。 這些參與者參與新產品開發被認為有助於 NTD 診斷市場的發展。

被忽視的熱帶病診斷市場報告亮點

  • 從疾病類型來看，由於患病率不斷上升以及診斷測試的廣泛採用，土源性蠕蟲病將在 2022 年佔據市場主導地位。
  • 由於分子診斷技術的研發以及對即時護理產品的需求增加，2022 年的市場將由分子/高級診斷領域主導
  • 就 2022 年的市場份額而言，由於測試數量較多以及基礎設施和人力方面的廣泛輔助支持，集中式服務佔據最大部分。
  • 從最終用途來看，由於 POCT 服務越來越受歡迎和需求不斷增加，家庭醫療保健預計將成為增長最快的領域
  • 由於被忽視的熱帶疾病負擔沉重、醫療保健支出不斷增加、技術進步迅速，以及客戶對使用 PCR 檢測診斷被忽視熱帶疾病的意識不斷增強，亞太地區將在 2022 年主導全球市場。
  • 由於 IVD 產品的滲透率不斷提高以及新興國家 NTD 的高疾病負擔，預計拉丁美洲未來將出現顯著增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
    • 信息分析
    • 市場形成和數據可視化
    • 驗證和發布數據
  • 調查先決條件
  • 信息獲取
    • 初步調查
  • 信息或數據分析
  • 市場形成和驗證
  • 市場模式
  • 全球市場：計算複合年增長率
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/輔助市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 行業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 感染的影響分析

第四章疾病業務分析

  • 被忽視的熱帶病診斷市場：疾病波動分析
  • 登革熱
  • 基孔肯雅熱
  • 狂犬病
  • 麻風病
  • 布魯裡潰瘍
  • 余澤
  • 淋巴絲蟲病
  • 絛蟲病/囊尾蚴病
  • 食物中毒吸蟲感染
  • 包蟲病
  • 恰加斯病
  • 麥地那龍線蟲病
  • 人類非洲錐蟲病（昏睡病）
  • 土源性蠕蟲病
  • 盤尾絲蟲病
  • 血吸蟲病
  • 疥瘡和其他生態寄生蟲
  • 蛇咬傷毒液
  • 利甚曼病

第五章診斷方法的業務分析

  • 被忽視的熱帶病診斷市場：診斷方法的變異分析
  • 傳統方法
  • 分子/現代方法

第六章服務類型業務分析

  • 被忽視的熱帶病診斷市場：服務類型的變化分析
  • 集中服務
  • POC 服務

第 7 章：最終用途業務分析

  • 被忽視的熱帶病診斷市場：最終用途變異分析
  • 臨床實驗室
    • 實驗室檢測市場，2018-2030
    • 醫院和診所
    • 家庭醫療保健

第 8 章區域業務分析

  • 2022 年和 2030 年被忽視的熱帶病診斷市場份額（按地區）
  • 北美
    • SWOT分析
    • 北美被忽視的熱帶病診斷市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 歐洲被忽視的熱帶病診斷市場，2018-2030
    • 英國
    • 德國
  • 亞太地區
    • SWOT分析
    • 2018-2030 年亞太地區被忽視的熱帶病診斷市場
    • 中國
    • 印度
    • 印度尼西亞
    • 馬來西亞
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲被忽視的熱帶病診斷市場，2018-2030 年
    • 巴西
    • 哥倫比亞
    • 委內瑞拉
  • MEA
    • SWOT分析
    • MEA 被忽視的熱帶病診斷市場，2018-2030 年
    • 尼日利亞

第 9 章競爭格局

  • 公司分類
  • 戰略規劃
  • 2022 年公司市場份額分析
  • 公司簡介/列表
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix, LLC
    • InBios International, Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • GmbH Oscar Medicare Pvt Ltd.
Product Code: GVR-2-68038-319-5

Neglected Tropical Diseases Diagnosis Market Growth & Trends

The global neglected tropical diseases diagnosis market size is expected to reach USD 8.97 billion by 2030, expanding at a CAGR of 4.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Disease Diagnosis Market Report Highlights

  • By disease type, the soil-transmitted helminthiases dominated the market in 2022, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2022, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2022 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2022, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of neglected tropical diseases
      • 3.2.1.2. Growing investments and governmental funding in the development of diagnostics
      • 3.2.1.3. Growing awareness of neglected tropical diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shift of funds to tackle other diseases in low health budgets
      • 3.2.2.2. Shortage of funding from international partners and foreign government
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Disease Business Analysis

  • 4.1. Neglected Tropical Disease Diagnosis Market: Disease Movement Analysis
  • 4.2. Dengue
    • 4.2.1. Dengue Market, 2018 - 2030 (USD Million)
  • 4.3. Chikungunya
    • 4.3.1. Chikungunya Market, 2018 - 2030 (USD Million)
  • 4.4. Rabies
    • 4.4.1. Rabies Market, 2018 - 2030 (USD Million)
  • 4.5. Leprosy
    • 4.5.1. Leprosy Market, 2018 - 2030 (USD Million)
  • 4.6. Buruli Ulcer
    • 4.6.1. Buruli Ulcer Market, 2018 - 2030 (USD Million)
  • 4.7. Yaws
    • 4.7.1. Yaws Market, 2018 - 2030 (USD Million)
  • 4.8. Lymphatic Filariasis
    • 4.8.1. Lymphatic Filariasis Market, 2018 - 2030 (USD Million)
  • 4.9. Taeniasis/Cysticercosis
    • 4.9.1. Taeniasis/Cysticercosis Market, 2018 - 2030 (USD Million)
  • 4.10. Foodborne Trematode Infections
    • 4.10.1. Foodborne Trematode Infections Market, 2018 - 2030 (USD Million)
  • 4.11. Echinococcosis
    • 4.11.1. Echinococcosis Market, 2018 - 2030 (USD Million)
  • 4.12. Chagas Disease
    • 4.12.1. Chagas Disease Market, 2018 - 2030 (USD Million)
  • 4.13. Dracunculiasis
    • 4.13.1. Dracunculiasis Market, 2018 - 2030 (USD Million)
  • 4.14. Human African Trypanosomiasis (Sleeping Sickness)
    • 4.14.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2018 - 2030 (USD Million)
  • 4.15. Soil-Transmitted Helminthiases
    • 4.15.1. Soil-Transmitted Helminthiases Market, 2018 - 2030 (USD Million)
  • 4.16. Onchocerciasis
    • 4.16.1. Onchocerciasis Market, 2018 - 2030 (USD Million)
  • 4.17. Schistosomiasis
    • 4.17.1. Schistosomiasis Market, 2018 - 2030 (USD Million)
  • 4.18. Scabies and Other Ecoparasites
    • 4.18.1. Scabies and Other Ecoparasites Market, 2018 - 2030 (USD Million)
  • 4.19. Snakebite Envenoming
    • 4.19.1. Snakebite Envenoming Market, 2018 - 2030 (USD Million)
  • 4.20. Leishmaniases
    • 4.20.1. Leishmaniases Market, 2018 - 2030 (USD Million)

Chapter 5. Diagnostic Method Business Analysis

  • 5.1. Neglected Tropical Disease Diagnosis Market: Diagnostic Method Movement Analysis
  • 5.2. Conventional Method
    • 5.2.1. Conventional Method Market, 2018 - 2030 (USD Million)
  • 5.3. Molecular/Modern Method
    • 5.3.1. Molecular/Modern Method Market, 2018 - 2030 (USD Million)

Chapter 6. Service Type Business Analysis

  • 6.1. Neglected Tropical Disease Diagnosis Market: Service Type Movement Analysis
  • 6.2. Centralized Service
    • 6.2.1. Centralized Service Market, 2018 - 2030 (USD Million)
  • 6.3. POC Service
    • 6.3.1. POC Service Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Neglected Tropical Disease Diagnosis Market: End-Use Movement Analysis
  • 7.2. Clinical Labs
    • 7.2.1. Clinical Labs Market, 2018 - 2030 (USD Million)
    • 7.2.2. Hospital/Clinics
      • 7.2.2.1. Hospital/Clinics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Home Healthcare
      • 7.2.3.1. Home Healthcare Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Neglected Tropical Disease Diagnosis Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Canada Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.5. Indonesia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Indonesia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.6. Malaysia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Malaysia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.4. Colombia
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Colombia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.5. Venezuela
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Venezuela Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.6.3. Nigeria
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Nigeria Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Abbott
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. ZeptoMetrix, LLC
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. InBios International, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Genome Diagnostics Pvt. Ltd.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Omega Diagnostics Group PLC
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Coris BioConcept
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. DiaSys Diagnostic Systems GmbH
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. GmbH Oscar Medicare Pvt Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 5 Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 6 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 7 Global Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 10 North America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 11 North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 12 North America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 14 U.S. Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 15 U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Canada Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 19 Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 21 Europe Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 23 Europe Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 24 Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 25 Europe Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 26 UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 27 UK Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 28 UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 UK Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 Germany Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 32 Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 33 Germany Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 39 China Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 China Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 41 China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 42 China Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 43 India Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 44 India Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 45 India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 46 India Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 47 Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 48 Indonesia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 49 Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 50 Indonesia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 51 Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 52 Malaysia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 53 Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 54 Malaysia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 55 Latin America Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 56 Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 57 Latin America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 58 Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 59 Latin America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 60 Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 61 Brazil Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 62 Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 63 Brazil Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 64 Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 Colombia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 66 Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 67 Colombia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 68 Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 69 Venezuela Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 70 Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 71 Venezuela Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 77 Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 78 Nigeria Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 79 Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 80 Nigeria Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Neglected Tropical Diseases Diagnosis Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Neglected tropical diseases diagnosis market: Disease outlook and key takeaways
  • Fig. 15 Neglected tropical diseases diagnosis market: Disease movement analysis & market share 2022 & 2030
  • Fig. 16 Dengue neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 17 Chikungunya neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 18 Rabies market, 2018 - 2030 (USD Million)
  • Fig. 19 Leprosy neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 20 Buruli ulcer neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 21 Yaws market, 2018 - 2030 (USD Million)
  • Fig. 22 Lymphatic filariasis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 23 Taeniasis/Cysticercosis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 24 Foodborne trematode infections market, 2018 - 2030 (USD Million)
  • Fig. 25 Echinococcosis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 26 Chagas disease neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 27 Dracunculiasis market, 2018 - 2030 (USD Million)
  • Fig. 28 Human African trypanosomiasis (sleeping sickness) neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 29 Soil-transmitted helminthiases neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 30 Onchocerciasis market, 2018 - 2030 (USD Million)
  • Fig. 31 Schistosomiasis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 32 Scabies and other ecoparasites neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 33 Snakebite envenoming market, 2018 - 2030 (USD Million)
  • Fig. 34 Leishmaniases market, 2018 - 2030 (USD Million)
  • Fig. 35 Neglected tropical diseases diagnosis market: Diagnostic method outlook and key takeaways
  • Fig. 36 Neglected tropical diseases diagnosis market: Diagnostic method movement analysis & market share 2022 & 2030
  • Fig. 37 Conventional method market, 2018 - 2030 (USD Million)
  • Fig. 38 Molecular/Modern method market, 2018 - 2030 (USD Million)
  • Fig. 39 Neglected tropical diseases diagnosis market: Service type outlook and key takeaways
  • Fig. 40 Neglected tropical diseases diagnosis market: Service type movement analysis & market share 2022 & 2030
  • Fig. 41 Centralized service neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 42 POC service neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 43 Neglected tropical diseases diagnosis market: End-Use outlook and key takeaways
  • Fig. 44 Neglected tropical diseases diagnosis market: End-Use movement analysis & market share 2022 & 2030
  • Fig. 45 Clinical labs neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 46 Hospitals/Clinics neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 47 Home healthcare neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 48 Regional Marketplace: Key Takeaways
  • Fig. 49 Regional Outlook, 2022 & 2030
  • Fig. 50 Regional Market Dashboard
  • Fig. 51 Regional Market Place: Key Takeaways
  • Fig. 52 North America, SWOT Analysis
  • Fig. 53 Europe, SWOT Analysis
  • Fig. 54 Asia Pacific, SWOT Analysis
  • Fig. 55 Latin America, SWOT Analysis
  • Fig. 56 MEA, SWOT Analysis
  • Fig. 57 North America
  • Fig. 58 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 U.S.
  • Fig. 60 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Canada
  • Fig. 62 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Europe
  • Fig. 64 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 UK
  • Fig. 66 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Germany
  • Fig. 68 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 China
  • Fig. 72 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 74 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Indonesia
  • Fig. 76 Indonesia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Malaysia
  • Fig. 78 Malaysia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America
  • Fig. 80 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil
  • Fig. 82 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Colombia
  • Fig. 84 Colombia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 MEA
  • Fig. 86 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Nigeria
  • Fig. 88 Nigeria Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Strategy Mapping